Gastroesophageal reflux disease (GERD) affects an estimated 1.03 billion people worldwide, with prevalence ranging significantly by region. Defined as a condition where stomach contents reflux causes troublesome symptoms like heartburn and regurgitation, GERD’s diagnosis often involves endoscopy and reflux monitoring, especially for patients unresponsive to initial treatments. Advanced diagnostic tools such as pH or impedance-pH monitoring and high-resolution esophageal manometry help clinicians confirm GERD and assess for surgical suitability in more severe cases. Evolving treatments include tailored use of proton pump inhibitors (PPIs), novel medical therapies, and endoscopic procedures. Explore the full article for a comprehensive review of diagnostic and management strategies that are helping clinicians better address this pervasive condition.
Trending
- GI 2.0: The Playbook | Chapter 8 | The AI-Native GI Practice
- The physician referral black hole is swallowing your growth (BPD)
- Could corporate medicine be on the way out? Inside the new federal bill (MDLinx)
- Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity (The New England Journal of Medicine)
- Microbiome Holds Biomarker Predictive of CRC Recurrence (GI & Endoscopy News)
- Are You Performing Second Inspection of the Right Colon? (GI & Endoscopy News)
- The AI Is in the Scope. The Evidence Isn’t. (CDO Trends Weekly)
- Updated Diagnostic Criteria for Acute Severe Ulcerative Colitis (Medscape)
